A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems

Real-time monitoring of tumor drug delivery in vivo is a daunting challenge due to the heterogeneity and complexity of the tumor microenvironment. In this study, we developed a biomimetic microfluidic tumor microenvironment (bMTM) comprising co-culture of tumor and endothelial cells in a 3D environment. The platform consists of a vascular compartment featuring a network of vessels cultured with endothelial cells forming a complete lumen under shear flow in communication with 3D solid tumors cultured in a tumor compartment. Endothelial cell permeability to both small dye molecules and large liposomal drug carriers were quantified using fluorescence microscopy. Endothelial cell intercellular junction formation was characterized by immunostaining. Endothelial cell permeability significantly increased in the presence of either tumor cell conditioned media (TCM) or tumor cells. The magnitude of this increase in permeability was significantly higher in the presence of metastatic breast tumor cells as compared to non-metastatic ones. Immunostaining revealed impaired endothelial cell-cell junctions in the presence of either metastatic TCM or metastatic tumor cells. Our findings indicate that the bMTM platform mimics the tumor microenvironment including the EPR effect. This platform has a significant potential in applications such as cell-cell/cell-drug carrier interaction studies and rapid screening of cancer drug therapeutics/carriers.

[1]  E. Sevick-Muraca,et al.  Fluid shear stress activates YAP1 to promote cancer cell motility , 2017, Nature Communications.

[2]  G. Wood,et al.  Targeting of the Antivascular Drug Combretastatin to Irradiated Tumors Results in Tumor Growth Delay , 2005, Pharmaceutical Research.

[3]  A. Ridley,et al.  Crossing the endothelial barrier during metastasis , 2013, Nature Reviews Cancer.

[4]  Alok R. Khandelwal,et al.  Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells. , 2016, American journal of translational research.

[5]  P. Lin,et al.  Endothelial cell adhesion molecules and cancer progression. , 2007, Current medicinal chemistry.

[6]  Nicholas Denko,et al.  Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment , 2006, Molecular Cancer Research.

[7]  S. Quake,et al.  Versatile, fully automated, microfluidic cell culture system. , 2007, Analytical chemistry.

[8]  L. Richard,et al.  How can grafted breast cancer models be optimized? , 2011, Cancer biology & therapy.

[9]  D. Mu,et al.  Tight junction proteins: from barrier to tumorigenesis. , 2013, Cancer letters.

[10]  Noo Li Jeon,et al.  A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation. , 2014, Biomicrofluidics.

[11]  C. Astete,et al.  Synthesis and characterization of PLGA nanoparticles , 2006, Journal of biomaterials science. Polymer edition.

[12]  Xingyu Jiang,et al.  Investigation of Tumor Cell Behaviors on a Vascular Microenvironment-Mimicking Microfluidic Chip , 2015, Scientific Reports.

[13]  Elisabetta Dejana,et al.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.

[14]  Brett S. Klosterhoff,et al.  Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip. , 2016, Molecular pharmaceutics.

[15]  R. Kamm,et al.  Microfluidic models of vascular functions. , 2012, Annual review of biomedical engineering.

[16]  M. Kiani,et al.  Abstract 16159: Targeted Delivery of a Dual Cathepsin G and Chymase Inhibitor by Immunoliposomes Augments Cardioprotection in Mice , 2016 .

[17]  H. Frieboes,et al.  An integrated computational/experimental model of tumor invasion. , 2006, Cancer research.

[18]  Mohammad F. Kiani,et al.  A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip , 2015, PloS one.

[19]  F. Danhier,et al.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Claudia Tanja Mierke,et al.  Cancer Cells Regulate Biomechanical Properties of Human Microvascular Endothelial Cells* , 2011, The Journal of Biological Chemistry.

[21]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[22]  L. Knight,et al.  Radiation-Guided Targeting of Combretastatin Encapsulated Immunoliposomes to Mammary Tumors , 2009, Pharmaceutical Research.

[23]  R. Cheheltani,et al.  Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[24]  Kapil Pant,et al.  Synthetic tumor networks for screening drug delivery systems. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Kapil Pant,et al.  Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. , 2011, Microvascular research.

[26]  Kinam Park,et al.  Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[27]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[28]  L. Moldawer,et al.  Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. , 2017, Cancer research.

[29]  Zhonggui He,et al.  The endocytosis and intracellular fate of nanomedicines: Implication for rational design , 2013 .

[30]  Joseph W. Nichols,et al.  EPR: Evidence and fallacy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Arihiro Kano,et al.  Tumor cell secretion of soluble factor(s) for specific immunosuppression , 2015, Scientific Reports.

[32]  Daniel Irimia,et al.  Synthetic microvascular networks for quantitative analysis of particle adhesion , 2008, Biomedical microdevices.

[33]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[34]  K. Sugihara,et al.  JTE‐522, a selective COX‐2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: A vascular cast model study , 2004, International journal of cancer.

[35]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[36]  Luke P. Lee,et al.  Integrated microfluidic cell culture and lysis on a chip. , 2007, Lab on a chip.

[37]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[38]  B. Fabry,et al.  Breakdown of the Endothelial Barrier Function in Tumor Cell Transmigration , 2007, Biophysical journal.

[39]  R. Jain,et al.  Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  M. Sontag,et al.  Early effects of ionizing radiation on the microvascular networks in normal tissue. , 1999, Radiation research.

[41]  Noah M. Roth,et al.  A “Geographic Information Systems” Based Technique for the Study of Microvascular Networks , 2004, Annals of Biomedical Engineering.

[42]  A. Molinari,et al.  Liposomes as nanomedical devices , 2015, International journal of nanomedicine.

[43]  Donald E. Mager,et al.  Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology , 2014, Pharmaceutics.

[44]  Aniruddha Roy,et al.  Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Fariborz Soroush,et al.  A novel microfluidic assay reveals a key role for protein kinase C δ in regulating human neutrophil–endothelium interaction , 2016, Journal of leukocyte biology.

[46]  K. Barbee,et al.  An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[47]  H. Maeda.  Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Dolly Mehta,et al.  Mechanisms Regulating Endothelial Permeability , 2014, Pulmonary circulation.

[49]  Jeonghoon Lee,et al.  Integration of microfluidic chip with biomimetic hydrogel for 3D controlling and monitoring of cell alignment and migration. , 2014, Journal of biomedical materials research. Part A.

[50]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[51]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[52]  T. Merchant,et al.  Radiation-induced permeability and leukocyte adhesion in the rat blood–brain barrier: modulation with anti-ICAM-1 antibodies , 2003, Brain Research.

[53]  L. Thoma,et al.  A tumor vasculature targeted liposome delivery system for combretastatin A4: Design, characterization, and in vitro evaluation , 2006, AAPS PharmSciTech.

[54]  R K Jain,et al.  Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Jain,et al.  Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks in vivo , 2010 .

[56]  M. King,et al.  Computational and Experimental Models of Cancer Cell Response to Fluid Shear Stress , 2013, Front. Oncol..

[57]  G. Rosner,et al.  Measurement of material extravasation in microvascular networks using fluorescence video-microscopy. , 1993, Microvascular research.

[58]  R K Jain,et al.  Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.

[59]  M. Sontag,et al.  Late Effects of Ionizing Radiation on the Microvascular Networks in Normal Tissue , 2000, Radiation research.

[60]  Roger D Kamm,et al.  Impact of the physical microenvironment on tumor progression and metastasis. , 2016, Current opinion in biotechnology.

[61]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[62]  Michael M. Schmidt,et al.  A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.

[63]  K. Pant,et al.  Bioinspired Microfluidic Assay for In Vitro Modeling of Leukocyte–Endothelium Interactions , 2014, Analytical chemistry.

[64]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[65]  H. Perlman,et al.  Humanizing the mouse: in defense of murine models of critical illness. , 2013, American journal of respiratory and critical care medicine.

[66]  Jan Schmidt,et al.  Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer. , 2004, World journal of gastroenterology.

[67]  Wei-Hua Huang,et al.  An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells. , 2015, Lab on a chip.

[68]  Anna Tourovskaia,et al.  Tissue-engineered microenvironment systems for modeling human vasculature , 2014, Experimental biology and medicine.

[69]  V. Torchilin,et al.  Current trends in the use of liposomes for tumor targeting. , 2013, Nanomedicine.

[70]  Bin Wang,et al.  Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. , 2016, Clinical breast cancer.